Clinical Trials
18 trialsNCT04902833 2026-05-19
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Massachusetts General Hospital
Completed
NCT07570407 2026-05-06
QiNKT-HSCT
University Hospital Pilsen
Not yet recruiting
NCT07249476 2026-04-29
ENKLA-M
Nantes University Hospital
Not yet recruiting
NCT06510868 2026-03-05
MDS & PRRT
University Health Network, Toronto
Recruiting
NCT05983991 2025-12-26
GATA-2
Institut Claudius Regaud
Phase NA Recruiting
NCT05735704 2025-03-26
SANGUINE
JaxBio Ltd
Unknown
NCT06045819 2025-02-28
Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)
University Hospital, Caen
Recruiting
NCT05854966 2024-09-19
CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT01904136 2024-01-24
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02602587 2019-05-13
OXYLAM
University Hospital, Toulouse
Phase NA Completed
NCT03337516 2017-11-09
Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers
Assistance Publique Hopitaux De Marseille
Phase NA Unknown
NCT03280290 2017-09-12
CCR7-CD4-DPL
University Hospital, Lille
Phase NA Completed
NCT02345915 2017-09-05
LEA-JA
Institut Paoli-Calmettes
Phase NA Unknown
NCT01471067 2017-04-28
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01176422 2017-01-10
Telomere and Telomerase
University of Kansas Medical Center
Withdrawn
NCT02860793 2016-08-10
LAM-PTK7
Institut Paoli-Calmettes
Phase NA Completed
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed
NCT00601991 2013-04-02
A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia
Vanderbilt-Ingram Cancer Center
Phase 2 Withdrawn